Home  >  Products  >  DDEFL1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain 3) Blocking Peptide (the N terminal of DDEFL1)(100ug)
DDEFL1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain 3) Blocking Peptide (the N terminal of DDEFL1)(100ug)

DDEFL1 (ArfGAP with SH3 domain, ankyrin repeat and PH domain 3) Blocking Peptide (the N terminal of DDEFL1)(100ug)


Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-DDEFL1 Antibody(ARP57013_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP57013
Size: 100ug
Weight: 99kDa
Gene: 55616
Format: Lyophilized powder
Target: This gene encodes a member of a subfamily of ADP-ribosylation factor(Arf) GTPase-activating proteins that contain additional ankyrin repeat and pleckstrin homology domains. The Arf GAP domain of this protein catalyzes the hydrolysis of GTP bound to Arf proteins. The encoded protein promotes cell differentiation and migration and has been implicated in cancer cell invasion. Alternative splicing results in multiple transcript variants.
Alternative names: ACAP4; CENTB6; FLJ20199; UPLC1